In the article “Assessment of Treatment Response in Patients with Glioblastoma Using O-(2-18F-Fluoroethyl)-l-Tyrosine PET in Comparison to MRI,” by Galldiks et al. (J Nucl Med. 2012;53:1048–1057), the abstract mistakenly stated, “Receiver-operating-characteristic analysis showed that a decrease of the TBR(max) between FET-1 and FET-2 of more than 20% predicted poor survival….” However, such a decrease in fact predicted favorable survival, not poor survival. The authors regret the error.
- © 2013 by the Society of Nuclear Medicine and Molecular Imaging, Inc.